The Global Intracranial Aneurysm Market was valued at USD 1.6 billion in 2025 and is estimated to grow at a CAGR of 9.1% to reach USD 4 billion by 2035.
Market expansion is driven by rapid progress in minimally invasive neurovascular technologies, a growing clinical preference for endovascular therapies over open surgical approaches, and the rising incidence of intracranial aneurysms worldwide. An intracranial aneurysm is defined as a localized weakening and outward bulging of a cerebral blood vessel caused by arterial wall degeneration. Over time, this condition can worsen and carries a serious risk of rupture, which may result in life-threatening intracranial bleeding. These aneurysms are most identified near arterial junctions within the brain. Advancements in device engineering and procedural techniques have significantly improved treatment precision, reduced intervention time, and lowered complication rates. As healthcare systems increasingly prioritize less invasive treatment pathways, adoption of modern neurointerventional procedures continues to rise globally. Ongoing research initiatives and sustained innovation by leading manufacturers are improving patient outcomes and supporting consistent market growth across developed and emerging healthcare systems.
The endovascular coiling segment held a 66.7% share in 2025 owing to its minimally invasive approach and strong clinical performance. This technique is widely favored for both ruptured and unruptured aneurysms, particularly among elderly patients and individuals with elevated surgical risk. Shorter recovery timelines and reduced procedural burden continue to support its role as a primary treatment option, with procedure volumes rising as hospitals expand minimally invasive care models.
The hospitals segment accounted for a 65% share in 2025 and is expected to generate USD 2.5 billion through 2035. High patient admissions related to acute neurovascular events and aneurysm complications are driving demand for hospital-based treatment. Hospitals provide integrated access to specialized clinicians, advanced imaging, and intensive care, enabling rapid and coordinated management of complex aneurysm cases.
North America Intracranial Aneurysm Market held a 41.7% share in 2025. The region experiences a high disease burden linked to aging populations and lifestyle-related risk factors. Increased screening rates and early diagnosis are supporting treatment demand. Well-established neurovascular infrastructure and advanced procedural capabilities further strengthen regional market leadership.
Key companies operating in the Global Intracranial Aneurysm Market include Medtronic, Stryker, TERUMO, Johnson & Johnson, Penumbra, B. BRAUN, Balt Group, MicroPort, INTEGRA, Shape Memory Medical, phenox, Wallaby Medical, ZYLOX TONBRIDGE, MIZUHO, and Peter LAZIC. Companies in the Global Intracranial Aneurysm Market are reinforcing their market position through sustained investment in research, technology refinement, and clinical validation. Manufacturers are focused on developing safer, more effective minimally invasive solutions that improve long-term patient outcomes. Strategic partnerships with hospitals and research institutions help accelerate product adoption and clinical acceptance. Geographic expansion into underserved regions supports volume growth, while regulatory approvals strengthen global reach. Many players are also investing in physician training programs and procedural education to increase familiarity with advanced treatment options.
This product will be delivered within 2-4 business days.
Market expansion is driven by rapid progress in minimally invasive neurovascular technologies, a growing clinical preference for endovascular therapies over open surgical approaches, and the rising incidence of intracranial aneurysms worldwide. An intracranial aneurysm is defined as a localized weakening and outward bulging of a cerebral blood vessel caused by arterial wall degeneration. Over time, this condition can worsen and carries a serious risk of rupture, which may result in life-threatening intracranial bleeding. These aneurysms are most identified near arterial junctions within the brain. Advancements in device engineering and procedural techniques have significantly improved treatment precision, reduced intervention time, and lowered complication rates. As healthcare systems increasingly prioritize less invasive treatment pathways, adoption of modern neurointerventional procedures continues to rise globally. Ongoing research initiatives and sustained innovation by leading manufacturers are improving patient outcomes and supporting consistent market growth across developed and emerging healthcare systems.
The endovascular coiling segment held a 66.7% share in 2025 owing to its minimally invasive approach and strong clinical performance. This technique is widely favored for both ruptured and unruptured aneurysms, particularly among elderly patients and individuals with elevated surgical risk. Shorter recovery timelines and reduced procedural burden continue to support its role as a primary treatment option, with procedure volumes rising as hospitals expand minimally invasive care models.
The hospitals segment accounted for a 65% share in 2025 and is expected to generate USD 2.5 billion through 2035. High patient admissions related to acute neurovascular events and aneurysm complications are driving demand for hospital-based treatment. Hospitals provide integrated access to specialized clinicians, advanced imaging, and intensive care, enabling rapid and coordinated management of complex aneurysm cases.
North America Intracranial Aneurysm Market held a 41.7% share in 2025. The region experiences a high disease burden linked to aging populations and lifestyle-related risk factors. Increased screening rates and early diagnosis are supporting treatment demand. Well-established neurovascular infrastructure and advanced procedural capabilities further strengthen regional market leadership.
Key companies operating in the Global Intracranial Aneurysm Market include Medtronic, Stryker, TERUMO, Johnson & Johnson, Penumbra, B. BRAUN, Balt Group, MicroPort, INTEGRA, Shape Memory Medical, phenox, Wallaby Medical, ZYLOX TONBRIDGE, MIZUHO, and Peter LAZIC. Companies in the Global Intracranial Aneurysm Market are reinforcing their market position through sustained investment in research, technology refinement, and clinical validation. Manufacturers are focused on developing safer, more effective minimally invasive solutions that improve long-term patient outcomes. Strategic partnerships with hospitals and research institutions help accelerate product adoption and clinical acceptance. Geographic expansion into underserved regions supports volume growth, while regulatory approvals strengthen global reach. Many players are also investing in physician training programs and procedural education to increase familiarity with advanced treatment options.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Treatment Type, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 8 Company Profiles
Companies Mentioned
The companies profiled in this Intracranial Aneurysm market report include:- B. BRAUN
- Balt Group
- INTEGRA
- Johnson & Johnson
- Medtronic
- MicroPort
- MIZUHO
- Penumbra
- Peter LAZIC
- phenox
- Shape Memory Medical
- Stryker
- TERUMO
- Wallaby Medical
- ZYLOX TONBRIDGE
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | December 2025 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 1.6 Billion |
| Forecasted Market Value ( USD | $ 4 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
